• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度泰米尔纳德邦韦洛尔城乡高危患者中他汀类药物的使用情况:一项基于人群的横断面研究。

Prevalence of statin use among high-risk patients in urban and rural Vellore, Tamil Nadu: A population-based cross-sectional study.

作者信息

Oommen Anu Mary, Nand Khushboo, Abraham Vinod Joseph, George Kuryan, Jose V Jacob

机构信息

Department of Community Health, Christian Medical College, Vellore, Tamil Nadu, India.

Department of Cardiology, Christian Medical College, Vellore, Tamil Nadu, India.

出版信息

Indian J Pharmacol. 2017 Mar-Apr;49(2):201-204. doi: 10.4103/ijp.IJP_747_16.

DOI:10.4103/ijp.IJP_747_16
PMID:28706335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5497444/
Abstract

OBJECTIVES

This study assessed statin use among diabetics and those with coronary heart disease (CHD) in Vellore, Tamil Nadu.

METHODS

A cross-sectional survey was conducted in rural and urban Vellore, among 6196 participants (30-64 years), in 2010-2012. Statin use among those with known CHD and diabetes (on diabetic medication) was recorded. A randomly selected sample of rural diabetics was resurveyed in 2016 to reassess statin use.

RESULTS

Among 61 with CHD, 23 (37.7%) were on statins. Statin use among 422 diabetics aged ≥40 years with low-density lipoprotein ≥70 mg/dl was 13.4% in urban and 7.6% among rural. Statin usage among rural diabetics aged ≥40 years increased from 7.7% in 2010-2012 to 16.6% in 2016.

CONCLUSIONS

Statin use for CHD was below 50% although higher than the use among diabetics, indicating the need to address this low rate of usage among these high-risk groups.

摘要

目的

本研究评估了印度泰米尔纳德邦韦洛尔地区糖尿病患者和冠心病(CHD)患者的他汀类药物使用情况。

方法

2010 - 2012年,在韦洛尔农村和城市地区对6196名年龄在30 - 64岁的参与者进行了横断面调查。记录已知患有冠心病和糖尿病(正在服用糖尿病药物)患者的他汀类药物使用情况。2016年对随机抽取的农村糖尿病患者样本进行了重新调查,以重新评估他汀类药物的使用情况。

结果

在61名冠心病患者中,23名(37.7%)正在服用他汀类药物。在422名年龄≥40岁、低密度脂蛋白≥70 mg/dl的糖尿病患者中,城市患者的他汀类药物使用率为13.4%,农村患者为7.6%。农村年龄≥40岁糖尿病患者的他汀类药物使用率从2010 - 2012年的7.7%增至2016年的16.6%。

结论

冠心病患者的他汀类药物使用率低于50%,但高于糖尿病患者,这表明有必要解决这些高危人群中他汀类药物使用率低的问题。

相似文献

1
Prevalence of statin use among high-risk patients in urban and rural Vellore, Tamil Nadu: A population-based cross-sectional study.印度泰米尔纳德邦韦洛尔城乡高危患者中他汀类药物的使用情况:一项基于人群的横断面研究。
Indian J Pharmacol. 2017 Mar-Apr;49(2):201-204. doi: 10.4103/ijp.IJP_747_16.
2
Prevalence of coronary heart disease in rural and urban Vellore: A repeat cross-sectional survey.韦洛尔城乡冠心病患病率:一项重复横断面调查。
Indian Heart J. 2016 Jul-Aug;68(4):473-9. doi: 10.1016/j.ihj.2015.11.015. Epub 2016 Jan 11.
3
Intracluster correlation estimates from a World Health Organisation STEPwise approach to surveillance (STEPS) survey for cardiovascular risk factors in Vellore, Tamil Nadu, India.印度泰米尔纳德邦维洛尔世界卫生组织心血管危险因素监测(STEPS)研究中的聚类相关系数估计值。
Public Health. 2019 Mar;168:102-106. doi: 10.1016/j.puhe.2018.12.019. Epub 2019 Feb 6.
4
Implementation of the American Diabetes Association's Standards of Medical Care post-Medicare Part D: The case of statin utilization in the elderly with diabetes.美国糖尿病协会医疗护理标准在医疗保险D部分实施后:老年糖尿病患者使用他汀类药物的情况
Res Social Adm Pharm. 2016 May-Jun;12(3):419-27. doi: 10.1016/j.sapharm.2015.08.001. Epub 2015 Aug 7.
5
Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.来自24个欧洲国家的冠心病患者的降脂药物治疗——EUROASPIRE IV调查结果
Atherosclerosis. 2016 Mar;246:243-50. doi: 10.1016/j.atherosclerosis.2016.01.018. Epub 2016 Jan 13.
6
Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.降脂治疗与中国福州高危心血管风险患者的低密度脂蛋白胆固醇(LDL-C)目标达标情况。
J Cardiovasc Pharmacol Ther. 2020 Jul;25(4):307-315. doi: 10.1177/1074248419899298. Epub 2020 Jan 10.
7
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.来自 3 个数据源的他汀类药物治疗患者的血脂异常患病率和血脂达标情况:一项回顾性分析。
J Am Heart Assoc. 2012 Dec;1(6):e001800. doi: 10.1161/JAHA.112.001800. Epub 2012 Dec 19.
8
Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States.美国依折麦布与他汀类药物联合治疗的经济学评估。
J Med Econ. 2017 Jul;20(7):723-731. doi: 10.1080/13696998.2017.1320559. Epub 2017 May 15.
9
Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.高危高血压患者是否接受联合他汀类药物治疗?:一项回顾性队列研究。
Am J Cardiovasc Drugs. 2009;9(5):299-308. doi: 10.2165/11312110-000000000-00000.
10
[Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011].[德国他汀类药物使用流行率的变化——1997 - 1999年和2008 - 2011年全国健康访谈与检查调查结果]
Z Evid Fortbild Qual Gesundhwes. 2017 May;122:22-31. doi: 10.1016/j.zefq.2017.04.001. Epub 2017 May 13.

引用本文的文献

1
Is there a difference in ischaemic heart disease deaths that occur without a preceding hospital admission in people who live in rural compared with urban areas of Aotearoa New Zealand? An observational study.在新西兰奥特亚罗瓦农村地区与城市地区的居民中,无前驱住院史的缺血性心脏病死亡情况是否存在差异?一项观察性研究。
BMJ Open. 2025 Feb 27;15(2):e088691. doi: 10.1136/bmjopen-2024-088691.
2
Vascular cognitive impairment in India: Challenges and opportunities for prevention and treatment.印度的血管性认知障碍:预防与治疗的挑战和机遇
Cereb Circ Cogn Behav. 2021 Nov 25;3:100034. doi: 10.1016/j.cccb.2021.100034. eCollection 2022.
3
Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice.2型糖尿病患者中他汀类药物的处方:指南与实践之间的临床差距。
J Res Med Sci. 2019 Feb 25;24:15. doi: 10.4103/jrms.JRMS_100_18. eCollection 2019.

本文引用的文献

1
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1.印度脂质协会2016年印度人血脂异常管理专家共识声明:第1部分。
J Assoc Physicians India. 2016 Mar;64(3 suppl):7-52.
2
The Lipid Association of India (LAI) Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: A Giant Leap Forward!印度脂质协会(LAI)2016年印度人血脂异常管理专家共识声明:向前迈出的巨大一步!
J Assoc Physicians India. 2016 Jun;64(6):102.
3
Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2.2 型糖尿病患者他汀类药物处方评估:印度心脏监测-2。
BMJ Open Diabetes Res Care. 2016 Aug 18;4(1):e000275. doi: 10.1136/bmjdrc-2016-000275. eCollection 2016.
4
Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.糖尿病患者他汀类药物使用的实践水平差异:来自PINNACLE注册研究的见解
J Am Coll Cardiol. 2016 Sep 20;68(12):1368-9. doi: 10.1016/j.jacc.2016.06.048.
5
Predictors of first-year statin medication discontinuation: A cohort study.他汀类药物治疗第一年停药的预测因素:一项队列研究。
J Clin Lipidol. 2016 Jul-Aug;10(4):987-995. doi: 10.1016/j.jacl.2016.04.010. Epub 2016 May 6.
6
Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012.美国成年人全国代表性样本中他汀类药物使用的患病率及相关因素:2011 - 2012年国家健康与营养检查调查
Clin Cardiol. 2016 Sep;39(9):491-6. doi: 10.1002/clc.22577. Epub 2016 Aug 9.
7
Educational status-related disparities in awareness, treatment and control of cardiovascular risk factors in India.印度心血管危险因素的知晓、治疗和控制方面与教育程度相关的差异。
Heart Asia. 2015 Jan 20;7(1):1-6. doi: 10.1136/heartasia-2014-010551. eCollection 2015.
8
Rising trend of cardiovascular risk factors between 1991-1994 and 2010-2012: A repeat cross sectional survey in urban and rural Vellore.1991 - 1994年至2010 - 2012年心血管危险因素的上升趋势:在韦洛尔城乡进行的重复横断面调查。
Indian Heart J. 2016 May-Jun;68(3):263-9. doi: 10.1016/j.ihj.2015.09.014. Epub 2016 Jan 13.
9
Assessment of adherence to cardiovascular medicines in rural population: An observational study in patients attending a tertiary care hospital.农村人口心血管药物依从性评估:一项针对三级医院就诊患者的观察性研究。
Indian J Pharmacol. 2015 Nov-Dec;47(6):600-4. doi: 10.4103/0253-7613.169573.
10
Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study.南亚社会经济因素与心血管疾病二级预防治疗的使用:PURE研究
Eur J Prev Cardiol. 2015 Oct;22(10):1261-71. doi: 10.1177/2047487314540386. Epub 2014 Jun 18.